Conference
Sorafenib (SOR) in patients (pts) with advanced/recurrent uterine carcinoma (UCA) or carcinosarcoma (CS): A phase II trial of the University of Chicago, PMH, and California Phase II Consortia
Authors
Nimeiri HS; Oza AM; Morgan RJ; Huo D; Elit L; Knost J; Wade JL; Agamah E; Vokes EE; Fleming GF
Volume
26
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
May 20, 2008
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
15
ISSN
0732-183X